Megan Bailey is the founder of Personal Genome Diagnostics. Personal Genome Diagnostics has raised $199M in total funding. Latest round: Series C.
Megan Bailey is the former CEO of Personal Genome Diagnostics (PGDx), a genomic testing company specializing in cancer genomics and liquid biopsy technologies. She led PGDx through a $103 million Series C funding round in 2021 and subsequently negotiated its $450 million acquisition by Labcorp in December 2021. Bailey currently serves as EVP & President of Labcorp Central Labs and International (Global Clinical Trials).
Full founder directory · Investor directory · Company funding database · Fundraising library